TEVA

39.2301.79%
MS

Matthew Shields

Executive Vice President of Global Operations

Mr. Matthew Shields, also known as Matt, is Executive Vice President of Global Operations of Teva Pharmaceutical Industries Limited from June 3, 2024. He is a manufacturing and supply chain leader with vast experience in the biopharmaceuticals and animal health industries. Prior to joining Teva, he was the Senior Vice President for Manufacturing at Merck Animal Health (known as MSD Animal Health outside of the United States and Canada), which he joined in 2020. Prior to his time at Merck Animal Health, he was a senior leader at Sanofi from 2017 to 2020, first serving as Head of Engineering and Operational Excellence for Sanofi?s Biologics organization from 2017 and later serving as Global Head of Sanofi?s Specialty Care Manufacturing organization from 2017 to 2020, during which time he also oversaw the commissioning and startup of Sanofi?s first digitally enabled continuous manufacturing facility. From 2000 to 2017, Mr. Shields served at Amgen, holding a series of increasingly senior leadership roles, including Head of Global Raw Material Supplier Relationships, Executive Director and Plant Manager in Singapore and Executive Director of Manufacturing. Mr. Shields received his undergraduate degree in Chemical Engineering and Materials Science Engineering from the University of Connecticut and a Master of Business Administration from Bryant University in Rhode Island. He serves on the board of the National Association of Manufacturers.

Positions